Stability of cefozopran hydrochloride in aqueous solutions

The influence of pH on the stability of cefozopran hydrochloride (CZH) was investigated in the pH range of 0.44-13.00. Six degradation products were identified with a hybrid ESI-Q-TOF mass spectrometer. The degradation of CZH as a result of hydrolysis was a pseudo-first-order reaction. As general acid-base hydrolysis of CZH was not occurred in the solutions of hydrochloric acid, sodium hydroxide, acetate, borate and phosphate buffers, kobs = kpH because specific acid-base catalysis was observed. Specific acid-base catalysis of CZH consisted of the following reactions: hydrolysis of CZH catalyzed by hydrogen ions (kH+), hydrolysis of dications (k1H2O), monocations (k2H2O) and zwitter ions (k3H2O) and hydrolysis of zwitter ions (k1OH-) and monoanions (k2OH-) of CZH catalyzed by hydroxide ions. The total rate of the reaction was equal to the sum of partial reactions: [Formula: see text]. CZH similarly like other fourth generation cephalosporin was most stable at slightly acidic and neutral pH and less stable in alkaline pH. The cleavage of the β-lactam ring resulting from a nucleophilic attack on the carbonyl carbon in the β-lactam moiety is the preferred degradation pathway of β-lactam antibiotics in aqueous solutions.

Medienart:

E-Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:42

Enthalten in:

Drug development and industrial pharmacy - 42(2016), 4 vom: 23., Seite 572-7

Sprache:

Englisch

Beteiligte Personen:

Zalewski, Przemysław [VerfasserIn]
Skibiński, Robert [VerfasserIn]
Paczkowska, Magdalena [VerfasserIn]
Garbacki, Piotr [VerfasserIn]
Talaczyńska, Alicja [VerfasserIn]
Cielecka-Piontek, Judyta [VerfasserIn]
Jelińska, Anna [VerfasserIn]

Links:

Volltext

Themen:

059QF0KO0R
Cefozopran hydrochloride
Cephalosporins
Degradation products
HPLC
Journal Article
Pharmaceutical Solutions
Q-TOF
Research Support, Non-U.S. Gov't
Stability in aqueous solutions
Water

Anmerkungen:

Date Completed 13.12.2016

Date Revised 13.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.3109/03639045.2015.1054834

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM250007274